(hennemusic) Motley Crue's North American stadium tour with Def Leppard and Poison earned more than $170 million, according to a new report by Billboard.
The 36-city series - with guests Poison and Joan Jett & The Blackhearts - sold 1.3 million tickets to deliver $173.5 million in revenue at the box office, which Billboard says makes it the biggest tour of either Motley Crue's or Def Leppard's career, dating back to when the Billboard Boxscore began collecting data in the late 1980s.
"The Stadium Tour" averaged 37,520 tickets each night, drawing more than three times the audience that each band previously reached on their own.
Motley Crue reunited for the series following a "farewell tour" that ended in 2015, while Def Leppard were on the road in support of their latest album, "Diamond Star Halos"; both bands have hinted that the tour will continue in 2023.
Read more here.
Motley Crue Add Fourth Show For 2024
Motley Crue's Tommy Lee Updates On Fans On Surgery Recovery
Mick Mars Streams Debut Album The Other Side Of Mars
Slayer, Iron Maiden, Motley Crue, Pantera and Slipknot Lead Aftershock Lineup
Kandace Springs - Run Your Race
On the Blue: New Horizons Cruise Day 1: Marbin Gets the Fun Started
Hot In The City: Prog Band Tu-Ner Coming to Phoenix
Def Leppard Celebrating Record Store Day With Double Silver Vinyl
Lacuna Coil Team With Ash Costello For 'In The Mean Time'
Telsa Releasing 'Real to Reel Vol I' For Record Store Day
Rolling Stones' Mick Jagger Pays Tribute To Count Manfredi Della Gherardesca Ahead Of Auction
Staind Get Animated For 'Better Days' Featuring Dorothy Video
Allman Brothers Band Pay Tribute To Dickey Betts
Kings of Leon Have 'Nothing To Do' With New Video
Pearl Jam Deliver New Album 'Dark Matter'